Design, synthesis and evaluation of genistein-polyamine conjugates as multi-functional anti-Alzheimer agents

A series of genistein-polyamine conjugates (4a-4h) were designed, synthesized and evaluated as multi-functional anti-Alzheimer agents. The results showed that these compounds had significant cholinesterases (ChEs) inhibitory activity. Compound 4b exhibited the strongest inhibition to acetylcholinest...

Full description

Saved in:
Bibliographic Details
Main Authors: Xin Zhang (Author), Jiang Wang (Author), Chen Hong (Author), Wen Luo (Author), Chaojie Wang (Author)
Format: Book
Published: Elsevier, 2015-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_2f34c43f463e4f558455655d78a7ac38
042 |a dc 
100 1 0 |a Xin Zhang  |e author 
700 1 0 |a Jiang Wang  |e author 
700 1 0 |a Chen Hong  |e author 
700 1 0 |a Wen Luo  |e author 
700 1 0 |a Chaojie Wang  |e author 
245 0 0 |a Design, synthesis and evaluation of genistein-polyamine conjugates as multi-functional anti-Alzheimer agents 
260 |b Elsevier,   |c 2015-01-01T00:00:00Z. 
500 |a 2211-3835 
500 |a 2211-3843 
500 |a 10.1016/j.apsb.2014.12.008 
520 |a A series of genistein-polyamine conjugates (4a-4h) were designed, synthesized and evaluated as multi-functional anti-Alzheimer agents. The results showed that these compounds had significant cholinesterases (ChEs) inhibitory activity. Compound 4b exhibited the strongest inhibition to acetylcholinesterase (AChE) with an IC50 value of 2.75 μmol/L, which was better than that of rivastigmine (5.60 μmol/L). Lineweaver-Burk plot and molecular modeling study showed that compound 4b targeted both the catalytic active site (CAS) and the peripheral anionic site (PAS) of AChE. Besides, compound 4b showed potent metal-chelating ability. In addition, it was found that 4a-4h did not affect HepG-2 cell viability at the concentration of 10 μmol/L. 
546 |a EN 
690 |a Genistein 
690 |a Polyamine 
690 |a Alzheimer׳s disease 
690 |a Acetylcholinesterase 
690 |a Molecular modeling 
690 |a Metal-chelating 
690 |a Inhibition 
690 |a Rivastigmine 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Acta Pharmaceutica Sinica B, Vol 5, Iss 1, Pp 67-73 (2015) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S2211383514001294 
787 0 |n https://doaj.org/toc/2211-3835 
787 0 |n https://doaj.org/toc/2211-3843 
856 4 1 |u https://doaj.org/article/2f34c43f463e4f558455655d78a7ac38  |z Connect to this object online.